Society for Pediatric Pathology
Menu

Grants and Awards


The Lotte Strauss Prize

Lotte Strauss Prize recognizes the meritorious work by an individual 40 years of age or younger in a subject germane to pediatric pathology, published or accepted for publication during the year immediately preceding the award. The deadline for application is Sunday, December 31th, 2017 at 23:59 and requires submission of a copy of the paper as a .pdf file, a letter from the nominee or sponsor (if the nominee is not an SPP member) explaining the nominee’s contribution to the work and the contribution of the paper to the field of pediatric pathology, and a copy of the nominee’s curriculum vitae. Lotte Strauss prize is awarded at the annual meeting and the awardee presents his/her research at the subsequent interim meeting.

Karen Chisholm, MD, PhD
Email: karen.chisholm@seattlechildrens.org

Year

Name

Title

Published

1986

Mark I. Greene, MD, PhD

Unavailable

1987

No award made

1988

No award made

1989

Hiroyuki Shimada, MD

Pathologic features of extraosseous Ewing’s sarcoma: a report from the Intergroup Rhabdomyosarcoma Study.

Human Pathology 1988;19:442-453

1990

Paul S. Thorner, MD, PhD

Abnormalities of the NCI domain of collagen type IV in GBM in canine hereditary nephritis.

Kidney International 1989;35:843-850

1991

Beverly Rogers, MD

Analysis of DNA in fresh and fixed tissue by the polymerase chain reaction.

Am J Pathol 1990;136:541-548

1992

David Witte, MD

Coordinate developmental regulation of purine catabolic enzyme expression in gastrointestinal and postimplantation reproductive tracts.

J Cell Biology 1991;115:179-190

1993

Stephen Qualman, MD

Correlation of neuropeptide expression in tumor tissue with other prognostic factors.

Cancer 1992;70: 2005-2012

1994

Poul H Sorensen, MD, PhD

A second Ewing’s sarcoma translocation t(21;22), fuses the EWS gene to another ETS-family transcription factor ERG.

Nature Genetics 1994;6:146

1995

Monique E DePaepe, MD

The transgenic SAD mouse: a model of human sickle cell glomerulopathy.

Kid Int. 1994;46: 1337-1345

1996

No award made

1997

Raj Kapur, MD, PhD

Abnormal microenvironmental signals underlie intestinal aganglionosis in Dominant megacolon mutant mice.

Dev Biol 1996;174:360-369.

1998

Brett Casey, MD

X-linked situs abnormalities result from mutations in ZIC3

Nature Genetics 1997;17:305-308

1999

Not awarded

2000

Anirban Maitra, MD

The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.

Cancer 1999; 85(3):741-749.

2001

Rusung Tan, MD

Cutting edge: defective natural killer cell activation in X-linked lymphoproliferative disease

J Immunol 2000;156:3549

2002

Jean-Christophe Fournet, MD, PhD

Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism. Association with a reduction of homozygosity of a mutation in ABCC8 or KCNJ11.

Am J Pathol 2002;158:2177

2003

Csaba Galambos, MD

Defective Pulmonary Development in the Absence of Heparin-Binding Vascular Endothelial Growth Factor Isoforms

Am J Respiratory Cell and Mol Biology, 2002;27:194-203.

2004

No award made

2005

Gail H. Deutsch, MD

Different thresholds of fibroblast growth factors pattern the ventral foregut into liver and lung

Development, 2005;132:35-47

2006

David Horst, MD, Dr. Med.

Comparative expression analysis of Pax3 and Pax7 during mouse myogenesis

Int. J. dev. Biol. 2006;50:47-54

2007

Rene L. Galindo, MD

A Drosophila model of the rhabdomyosarcoma initiator PAX7-FKHR

Proc. Natl. Acad. Sci. 2006;103:13439-13444

2008

Kudakwashe R. Chikwava, MB., ChB

Analysis of loss of heterozygosity in single-system and multisystem Langerhan’s cell histiocytosis.

Pediatr. Dev. Pathol., 2007;10:18-24

2009

Charles G. Mullighan MBBS(Hons), MSc, MD

BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

Nature 453: 110-4 2008

2010

Cynthia E. Hawkins, MD

Whole-Genome Profiling of Pediatric Diffuse Intrinsic Pontine Gliomas Highlights Platelet-Derived Growth Factor Receptor  and Poly (ADP-ribose) Polymerase As Potential Therapeutic Targets

J. Clin. Oncol. 28:

1337-1344, 2010

2011

Jefferson Terry, MD

PhD

Expression of CD133 in synovial sarcoma.

Appl Immunohistochem Mol Morphol

18; 159-165, 2010

2012

Kyle Kurek, MD

Loss-of-function mutations in PTPN11cause metachondromatosis, but not Ollier disease or Maffucci syndrome

PloS Genetics 2011;7(4):e10020500

2013

Robyn C. Reed, MD

Symmetrical peripheral gangrene in four pediatric cardiac surgery patients receiving extracorporeal membrane oxygenation.

Ped Dev Path 2012;15:217-225

2014

Benjamin Wilkins, MD

P53-mediated biliary defects caused by knockdown of cirhia, the zebrafish homolog of the gene responsible for North American Indian Childhood cirrhosis.

PLoS ONE 2013;8(10):e77670

2015

Erin R Rudzinski, MD

Myogenin, AP2b, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group.

Am J Surg Pathol 2014;38(5):654-659.

2016

Mariana M Cajaiba, MD

Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations

Hum Path 2016;48:81-87

2017

Miriam Conces, MD

A strategy for Helicobacter Immunohistochemistry utilization in pediatric practice

Am J Clin Pathol 2016;145(5): 611-617

Top